Geraedts, V.J.
36  results:
Search for persons X
?
1

Systematic Review - Combining Neuroprotection With Reperfus..:

Vos, E. M ; Geraedts, V. J ; van der Lugt, A...
https://pure.eur.nl/en/publications/0aa41aae-4ba2-4bec-979a-caf71833b7ce.  , 2022
 
?
2

Systematic Review - Combining Neuroprotection With Reperfus..:

Vos, E. M ; Geraedts, V. J ; van der Lugt, A...
https://pure.eur.nl/en/publications/0aa41aae-4ba2-4bec-979a-caf71833b7ce.  , 2022
 
?
 
?
4

Systematic Review - Combining Neuroprotection With Reperfus..:

E. M. Vos ; V. J. Geraedts ; A. van der Lugt...
https://www.frontiersin.org/articles/10.3389/fneur.2022.840892/full.  , 2022
 
?
6

IgA pemphigus as an immune checkpoint inhibitor-associated ..:

Bruijn, Tristan V. M ; Geraedts, Anne ; Vlahu, Carmen A..
https://research.vumc.nl/en/publications/64eaefc5-5486-49de-ab7c-a0f92969c182.  , 2024
 
?
7

A definitive prognostication system for patients with thora..:

Whisenant, JG ; Baena, J ; Cortellini, A...
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2022.  , 2022
 
?
8

Life-prolonging treatment restrictions and outcomes in pati..:

de Joode, Karlijn ; Tol, Jolien ; Hamberg, Paul...
https://research.rug.nl/en/publications/2725f9bc-b022-4af5-9cfc-cdf139ccde70.  , 2022
 
?
9

A Definitive Prognostication System for Patients With Thora..:

Whisenant, J. G ; Baena, J ; Cortellini, A...
https://pure.eur.nl/en/publications/57a1be43-ae85-4947-b4ba-97c8face5162.  , 2022
 
?
10

Coronavirus Disease 2019 Outcomes, Patient Vaccination Stat..:

Bestvina, C.M ; Whisenant, J.G ; Torri, V...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jtocrr.2022.100335.  , 2022
 
?
11

A Definitive Prognostication System for Patients With Thora..:

Whisenant, J. G ; Baena, J ; Cortellini, A...
https://pure.eur.nl/en/publications/57a1be43-ae85-4947-b4ba-97c8face5162.  , 2022
 
?
12

Life-prolonging treatment restrictions and outcomes in pati..:

de Joode, Karlijn ; Tol, Jolien ; Hamberg, Paul...
de Joode , K , Tol , J , the DOCC investigators , Hamberg , P , Cloos , M , Kastelijn , E A , Borgers , J S W , Nuij , V J A A , Klaver , Y , Herder , G J M , Mutsaers , P G N J , Dumoulin , D W , Oomen-de Hoop , E , van Diemen , N G J , Libourel , E J , Geraedts , E J , Bootsma , G P , van der Leest , C H , Peerdeman , A L , Herbschleb , K H , Visser , O J , Bloemendal , H J , van Laarhoven , H W M , de Vries , E G E , Hendriks , L E L , Beerepoot , L V , Westgeest , H M , van den Berkmortel , F W P J , Dingemans , A M C , van der Veldt , A A M , van Leeuwen , L , van der Meer , F S , Tiemessen , M A , van Diepen , D M , Brocken , P , Drooger , J C , de Groot , J W B , Stigt , J A , Slingerland , M , Haberkorn , B C M , Aarts , M J B , Youssef , M , Faber , L M , van de Wetering , R A W , Bard , M P L , Douma , G , Suijkerbuijk , K P M , Bakker , S D , de Jong , W K , Staal , A J & Franken , B 2022 , ' Life-prolonging treatment restrictions and outcomes in patients wi....  , 2022
 
?
15

Life-prolonging treatment restrictions and outcomes in pati..:

de Joode, Karlijn ; Tol, Jolien ; Hamberg, Paul...
https://pure.eur.nl/en/publications/76fb0cd3-e384-4869-be3d-af4cb2c0b03b.  , 2022
 
1-15